Proteasome inhibition by Carfilzomib, but not by Bortezomib, induces a specific, proteasome subunit-dependent impairment in cardiac contractility

Author(s):: Mendez, M.; Besse, A.; Besse, L.; Florea, B.I. (0000-0001-7114-2266); Christian, Z.; Overkleeft, H.S. (0000-0001-6992-4760); Driessen, C.

Published: 2019
Publication type: Article / Letter to editor

CardiotoxicityProteasome InhibitorProteomics

Date issued: 2019-10-31
Language: English
Is part of
hdl: 1887/3199176
doi: 10.1016/j.clml.2019.09.197
URL: https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(19)31584-8/pdf